Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III comparison of SMB budesonide-salmeterol DPI vs Seretide Diskus in moderate to severe persistent asthma
2006-001514-33Phase 3Completed
- Sponsor
- SMB Laboratoires
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of budesonide + salmeterol in asthma (2 arms), sponsored by SMB Laboratoires. Primary endpoint: Primary endpoint: mean change in morning peak expiratory flow. Started Apr 2006; status: completed.
02
Drugs
budesonide + salmeterol
03
Conditions
asthma
Beyond the preview
Go deeper on 2006-001514-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001514-33.